How immune cells recognize peptides during normal conditions and viral infections
Presentation of Qa-1 restricted peptides during homeostasis and viral infection
This study is looking at how a special immune molecule called Qa-1 helps our immune system recognize and respond to both our own proteins and those from viruses, which could help us find better ways to boost our body's defenses against infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-10814294 on NIH RePORTER |
What this research studies
This research investigates how a specific type of immune molecule, Qa-1, presents peptides from both self and viral proteins to immune cells, particularly during normal physiological conditions and viral infections. By using a specialized mouse model, the study aims to understand the mechanisms behind the presentation of these peptides and the resulting immune responses. The research focuses on the role of Qa-1 in regulating natural killer (NK) cells and CD8 T cells, which are crucial for fighting infections. This could lead to insights into how the immune system can be harnessed to improve responses to viral infections.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with viral infections or those interested in immune response mechanisms.
Not a fit: Patients with non-viral related immune disorders may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of immune responses, potentially leading to better vaccines and therapies for viral infections.
How similar studies have performed: Previous research has shown promising results in understanding immune responses related to similar mechanisms, indicating potential for success in this area.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Robey, Ellen a — University of California Berkeley
- Study coordinator: Robey, Ellen a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.